首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of opioid management

缩写:

ISSN:1551-7489

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引1080
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
R Wesley Vosburg,Kortney A Robinson R Wesley Vosburg
Background: The United States (US) is facing an opioid epidemic. Prescribed opioids are a contributor to this national issue. Strategies to reduce opioid prescriptions are a high priority. This study was designed to gener...
Ellen Childs,Holly Swan,Leigh Evans et al. Ellen Childs et al.
Objective: The Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care (6BBs) program provides a roadmap for improving the management of patients on opioid therapy for chronic pain. The g...
Jaycee A Blair,Savannah G Hansen Jaycee A Blair
Objective: Create a standardized protocol document on how to convert patients from full opioid agonist to buprenorphine. Providing patients with the best possible chance of a seamless conversion resulting in decreased ris...
Dylan Turner,Paul Gottselig,Leland Sommer et al. Dylan Turner et al.
Objective: To develop and implement a customized clinical decision support system (CDSS) in an under-resourced health region aimed at promoting appropriate and safe opioid prescribing. ...
Arnab Datta,Siddharth Sarkar Arnab Datta
Opioid Use Disorder (OUD) poses a significant public health challenge globally, with an estimated 23 million opioid users in India. Opioid Agonist Therapy (OAT) stands as the cornerstone of treatment, offering potential reductions in morbid...
Thomas Hickey,Gregory Acampora Thomas Hickey
Buprenorphine was synthesized in the 1960s as a result of a search for a safe and effective opioid analgesic. Present formulations of buprenorphine are approved for the treatment of both acute and chronic pain. Its long duration of action, ...
Takeshi Nakamura,Tomoyoshi Miyamoto,Daisuke Tanada et al. Takeshi Nakamura et al.
Objective: Tapentadol causes fewer gastrointestinal adverse events than other potent opioid analgesics because of its low affinity for opioid receptors; however, development of symptoms related to central nervous system d...
Nathaniel J Leavitt,Rachel S Sundman,Matthew White et al. Nathaniel J Leavitt et al.
Objective: The present opioid crisis has raised concern regarding the prescribing practices of physicians. However, the training of resident physicians has not been sufficiently evaluated. The proposed objective of this s...
Holly Sheldon,Nathan Duncan,Amit Singh et al. Holly Sheldon et al.
Objective: To implement an electronic health record best practice advisory (BPA) to promote coprescribing of naloxone to patients at high risk of serious opioid-related adverse events (ORADEs). ...
David W Boorman,Priyanka H Nair,Samuel B John et al. David W Boorman et al.
Objectives: Determine if physician stigma toward patients with chronic pain or opioid use disorder or physician hesitancy prescribing opioids adversely affects patient pain care. Explore the demographics associated with s...